Skip to main content
. 2009 May 26;27(21):3430–3436. doi: 10.1200/JCO.2008.18.4085

Fig 3.

Fig 3.

Disease-free survival by cyclophosphamide, doxorubicin, and fluorouracil (CAF) dose in tumors with topoisomerase (topo) II α amplification, deletion and normal copy number. Kaplan-Meier estimates were calculated using SAS 9.1 for disease-free survival by CAF dose (low, moderate, high) for tumors with topo IIα amplification, topo IIα deletion and topo IIα diploid (normal) copy number. P = .15, interaction term for the three arms.